NHS to review arthritis drugs use
The NHS treatment watchdog has agreed to review its guidance on the use of three drugs for rheumatoid arthritis. The National Institute for Health and Clinical Excellence (NICE) will look again at Humira, Enbrel and Remicade. Last year it ruled if a patient did not respond to one of the drugs - from a class known as anti-TNF medicines - they should not get another. But various charities, manufacturers and the Royal College of Nursing (RCN) appealed against that decision. The drugs will now undergo a further review of their NHS use.